HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hwan Mook Kim Selected Research

KBH A42

1/2012Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines.
3/2010KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein.
9/2009A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells.
10/2008Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hwan Mook Kim Research Topics

Disease

61Neoplasms (Cancer)
03/2021 - 08/2002
12Colorectal Neoplasms (Colorectal Cancer)
03/2021 - 07/2009
7Hypoxia (Hypoxemia)
03/2021 - 07/2009
7Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2009
7Inflammation (Inflammations)
09/2019 - 08/2005
7Neoplasm Metastasis (Metastasis)
01/2016 - 04/2006
5Breast Neoplasms (Breast Cancer)
04/2020 - 08/2006
5Leukemia
01/2020 - 06/2002
5Lung Neoplasms (Lung Cancer)
01/2016 - 04/2006
5Atopic Dermatitis (Atopic Eczema)
11/2008 - 10/2006
4Melanoma (Melanoma, Malignant)
01/2015 - 04/2006
2Pruritus (Itching)
07/2016 - 12/2015
2Dermatitis
12/2015 - 10/2006
2Pain (Aches)
09/2013 - 08/2013
2Edema (Dropsy)
08/2013 - 08/2005
2Prostatic Neoplasms (Prostate Cancer)
07/2013 - 10/2011
2Neuroinflammatory Diseases
03/2013 - 02/2012
2Obesity
12/2011 - 09/2011
2Rheumatoid Arthritis
08/2010 - 08/2005
2Arthritis (Polyarthritis)
08/2010 - 08/2005
2Contact Dermatitis (Eczema, Contact)
10/2008 - 12/2007
1Choroidal Neovascularization
09/2019
1Circulating Neoplastic Cells
04/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2018
1Necrosis
01/2017
1Neuralgia (Stump Neuralgia)
07/2016
1Hyperalgesia
07/2016

Drug/Important Bio-Agent (IBA)

12CalciumIBA
03/2021 - 01/2015
11Proteins (Proteins, Gene)FDA Link
09/2019 - 04/2003
9Pharmaceutical PreparationsIBA
01/2020 - 11/2005
9Histone Deacetylase InhibitorsIBA
07/2013 - 08/2006
8CytokinesIBA
12/2015 - 04/2006
7SaltsIBA
03/2021 - 02/2013
7Histone Deacetylases (Histone Deacetylase)IBA
03/2014 - 08/2006
6Lactic Acid (Lactate)FDA LinkGeneric
03/2021 - 01/2015
6LipidsIBA
01/2020 - 02/2010
5Antineoplastic Agents (Antineoplastics)IBA
11/2017 - 11/2006
5CaspasesIBA
02/2016 - 06/2002
5LactamsIBA
02/2011 - 08/2006
4Focal Adhesion Protein-Tyrosine KinasesIBA
11/2020 - 01/2015
4Biological ProductsIBA
11/2013 - 03/2006
4SilymarinIBA
05/2013 - 01/2004
4KBH A42IBA
01/2012 - 10/2008
4angelanIBA
12/2011 - 11/2006
4Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011 - 08/2002
4Polysaccharides (Glycans)IBA
01/2010 - 09/2005
3NF-kappa B (NF-kB)IBA
09/2019 - 02/2012
3Fluorouracil (Carac)FDA LinkGeneric
08/2018 - 01/2017
3EnzymesIBA
02/2013 - 09/2009
3glabridinIBA
10/2010 - 03/2005
3ZymosanIBA
10/2010 - 08/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 12/2007
3CeramidesIBA
11/2008 - 12/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 09/2019
2Glucose (Dextrose)FDA LinkGeneric
03/2021 - 01/2017
2Methionine (L-Methionine)FDA Link
05/2017 - 08/2011
2IDF-11774IBA
01/2017 - 01/2016
2AntioxidantsIBA
02/2016 - 06/2010
2Lipid NanoparticlesIBA
01/2016 - 11/2015
2Acetic Acid (Vinegar)FDA LinkGeneric
08/2013 - 08/2005
2CarrageenanIBA
08/2013 - 08/2005
2Ammonium CompoundsIBA
05/2013 - 02/2013
2Ethanol (Ethyl Alcohol)IBA
05/2013 - 03/2013
2Transforming Growth Factor beta (TGF-beta)IBA
12/2012 - 04/2002
2LipopolysaccharidesIBA
02/2012 - 01/2004
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2011 - 09/2011
24- hexadecanoyl- 1,1- dimethylpiperazin- 1- iumIBA
10/2011 - 03/2011
2Transcription Factors (Transcription Factor)IBA
10/2011 - 05/2006
2Irritants (Vesicants)IBA
10/2008 - 12/2007
2Hydroxamic Acids (Hydroxamic Acid)IBA
08/2006 - 03/2006
2TransferasesIBA
10/2003 - 04/2003
1Sorafenib (BAY 43-9006)FDA Link
11/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2020
1Hormones (Hormone)IBA
04/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
04/2020
1cedrolIBA
01/2020
1Membrane LipidsIBA
01/2020
1SphingomyelinsIBA
01/2020
1CholesterolIBA
01/2020
1SesquiterpenesIBA
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2019
1Retinal Pigments (Pigments, Visual)IBA
09/2019
1Capecitabine (Xeloda)FDA Link
08/2018
1ProdrugsIBA
08/2018
1Growth Factor ReceptorsIBA
04/2018
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2017
1Docetaxel (Taxotere)FDA Link
11/2017
1Methotrexate (Mexate)FDA LinkGeneric
05/2017
1ManganeseIBA
07/2016
1AcidsIBA
03/2016
1Betaine (C.B.B.)FDA Link
02/2016

Therapy/Procedure

14Therapeutics
01/2020 - 05/2006
4Drug Therapy (Chemotherapy)
04/2018 - 12/2007
3Oral Administration
05/2013 - 08/2005
3Immunotherapy
12/2011 - 01/2007
2Radiotherapy
04/2018 - 05/2009
2Aftercare (After-Treatment)
08/2011 - 12/2005
1Light Coagulation
09/2019
1Lasers (Laser)
09/2019
1Ligation
07/2016